Cubist Systematic Strategies, LLC Genocea Biosciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $9 - $1,242	-900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.96 - $1.35 $864 - $1,215	900 New	900 $1,000
Q3 2019 Nov 14, 2019	SELL	$2.9 - $4.07 $29,287 - $41,102	-10,099 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.71 $35,043 - $67,764	10,099 New	10,099 $40,000

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.